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COMMENTARY 
SENILE PLAQUES AND NEUROFIBRILLARY TANGLES: 
THE CONCURRENT LESIONS OF ALZHEIMER'S DISEASE 
MARK A.  SIVIITH, DAVID A.  DEWITT,  DARJA  PRAPROTNIK  AND GEORGE PERRY 
Department of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106 
ALZHEIMER'S disease (AD) is diagnostically and pathologi- 
cally characterized bythe concurrent presence of senile plaques 
(SP) and neurofibrillary tangles (NFT) (13), however, the reason 
why these two lesions are invaryingly present in AD is unknown. 
The preceding article by Trojanowski and co-workers expresses 
the view that concurrence i,;due to dependence (21). Whereas 
such interdependence between the lesions was proposed in the 
earliest studies of AD (reviewed in 22), and NFT develop all of 
the defined features of SP (12), several factors have made accep- 
tance of SP/NFT co-dependence problematic. For instance, 
amyloid eposition occurs in the absence of NFT (2,8), and mu- 
tations in the amyloid precursor protein directly link to AD (6). 
These apparent paradoxes make the simplicity of amyloid 
independence the most appealing. However, if one allows that 
the two different forms of SP may have distinct modes of for- 
mation (i.e., diffuse SP with little cellular abnormality and neu- 
ritic SP with abundant dystrophic neurites and glial reaction), 
it is apparent that one finds neuritic SP, the type related to 
dementia, only in the presence of NFT. Indeed, chronological 
studies indicate that diffuse SP are the first pathological marker 
and that NFT and neuritic SP occur together at a later time (2,8). 
Whether amyloid in the form of diffuse SP initiates further 
changes is unclear, however, it is clear that the cognitive and 
pathological markers of AD only occur with the co-occurrence 
of NFT and neuritic SP (10) that result in synaptic loss and con- 
sequent cognitive decline (9). Therefore, whereas the actual 
deposition of amyloid-B m~ty be unrelated to NFT it is becom- 
ing increasingly apparent that in Alzheimer's disease neuritic SP 
and NFT are inexorably linked. This codependence of the lesions 
is supported by several findings. 
1. Temporal correlation: In AD, Down syndrome and normal 
aging neuritic SP are coincidental with NFT (2,8). 
2. Morphological intermediates between NFT and SP are seen 
as extracellular NFT which invariably contain the defining 
traits of SP (i.e., amyloid, dystrophic neurites, microglia nd 
astroglia, and the same molecular deposits) (11,12). 
3. The dystrophic neurites of neuritic SP but not diffuse SP, 
invariably contain the same abnormal filaments found in 
NFT (3). 
4. The precursor protein of amyloid contains a/3-sheet confor- 
mation-dependent binding site for r protein, the major sub- 
unit of NFT (14,20). Furthermore, the interaction of r with 
B-protein precursor promotes fibrillogenesis (5). 
5. The dystrophic neurites of SP show membrane disruptions 
releasing B-protein precursor to the extracellular space sug- 
gesting a possible role in extracellular myloid-B deposition 
of SP (15). 
6. Implantation of PHF into the brain results in amyloid epo- 
sition (17). 
7. Familial AD cases with mutation of the/3-protein precursor 
gene show both amyloid deposition and NFT (7). 
One particularly interesting aspect of the article by Trojanow- 
ski et al. (21) is that only stabilized/polymerized r is able to elicit 
amyloid-~ deposition since normal r was only effective follow- 
ing treatment with A1C13 (16). PHF-r did not require stabiliza- 
tion by aluminum suggesting that PHF-r is intrinsically more 
stable. Whereas the increased number of phosphate moieties 
associated with PHF-r might account for this increased stability, 
another possibility are the post-translational advanced glycation 
end products associated with PHF-r that would stabilize PHF-r 
through the formation of protein crosslinks (!9,23). 
The presence of NFT in the absence or virtual absence of 
amyloid in subacute sclerosing encephalitis and Guam-dementia 
complex suggests that NFT may be one of several responses to 
neuronal insult and not specific for amyloid-B. The finding that 
amyloid-B is produced normally by many types of cells (18) and 
the relative lack of neurodegeneration associated with diffuse SP 
344 COMMENTARY ON TROJANOWSKI  ET AL. 
suggests that factors in addition to amyloid-i3 are required for 
a neuritic SP to form. Yet, the difference does not lie in amyloid- 
/3 because diffuse SP have amyloid-i3 fibrils (4) just as neuritic 
SP. However, diffuse SP do not show the substantial loss of syn- 
apses (9) and decreased neurite density observed in neuritic SP 
(1; personal observation). Neurodegeneration in the area where 
a SP will form could provide both neuronal factors as well as 
stimulate glial reactivity that promote amyloid-/3 deposition and 
potentiate neurodegeneration. This could lead to a positive feed- 
back loop in which amyloid-~ deposition contributes to neuro- 
degeneration which itself promotes more amyloid-~ deposition. 
Taken together with the preceding discussion, one can conclude 
that while amyloid-¢3 deposition as diffuse SP and NFT are inde- 
pendent lesions, in AD the development of neuritic SP and NFT 
are inexorably linked. Furthermore, in AD the presence of NFT 
and neuritic SP yields synergy between these two pathological 
processes. Importantly, such pathological synergy could utilize 
the connectivity of the brain to spread and lead to a disruption 
of that connectivity reflected by synapse loss. We would suggest 
that interrupting the synergistic interaction between NFT and 
amyloid-/3 might interrupt he progression of AD. 
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